Lactobacillus acidophilus ATCC 4356 attenuates the atherosclerotic progression through modulation of oxidative stress and inflammatory process

International Immunopharmacology

Volumn 17, Issue 1, 2013, Pages 108-115

  Chen, Lihua ^a   Liu, Wenen ^a   Li, Yanming ^a   Luo, San ^a   Liu, Qingxia ^a   Zhong, Yiming ^a   Jian, Zijuan ^a   Bao, Meihua ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Atherosclerosis; I B ; Lactobacillus acidophilus ATCC 4356; Oxidative stress; TNF

Indexed keywords

APOLIPOPROTEIN E; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LIPID; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROBIOTIC AGENT; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; AORTA ATHEROSCLEROSIS; ARTICLE; BODY WEIGHT; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; ENZYME DEGRADATION; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; LIPID BLOOD LEVEL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WILD TYPE;

EID: 84879233174     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.05.018     Document Type: Article

References (44)

1. Dahlöf B. Cardiovascular disease risk factors: epidemiology and risk assessment. Am J Cardiol 2010;105:3A-9A.
2. Lloyd-Jones DM. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation 2010;121:1768-77.
3. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
4. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 1999;85:753-66. (Pubitemid 29480816)
5. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011;3:204-12.
6. Rader DJ, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature 2008;451:904-14.
7. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998;78:547-81. (Pubitemid 28182903)
8. Hudault S, Lieven B, Bernet-Camard MF, Servin AL. Antagonostic activity exerted in vitro and in vivo by Lactiobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 1997;63:513-8. (Pubitemid 27121332)
9. Kawashima T, Hayashi K, Kosaka A, Kawashima M, Igarashi T, Tsutsui H, et al. Lactobacillus plantarum strain YU from fermented foods activates Th1 and protective immune responses. Int Immunopharmacol 2011;12:2017-24.
10. Lee DK, Jang S, Baek EH, Kim MJ, Lee KS, Shin HS, et al. Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content. Lipids Health Dis 2009. http://dx.doi.org/10.1186/1476- 511X-8-21.
11. Nishitani Y, Tanoue T, Yamada K, Ishida T, Yoshida M, Azuma T, et al. Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice. Int Immunopharmacol 2009;12:1444-51.
12. Anukam KC, Reid G. African traditional fermented foods and probiotics. J Med Food 2009;6:1177-84.
13. Donohue DC. Safety of probiotics. Asia Pac J Clin Nutr 2006;15:563-9. (Pubitemid 44905138)
14. Chiu CH, Lu TY, Tseng YY, Pan TM. The effects of Lactobacillus-fermented milk on lipid metabolism in hamsters fed on high-cholesterol diet. Applied microbial and cell 2006;2:238-45.
15. Cavallini DC, Suzuki JY, Abdalla DS, Vendramini RC, Pauly-Silveira ND, Roselino MN, et al. Influence of a probiotic soy product on fecal microbiota and its association with cardiovascular risk factors in an animal model. Lipids Health Dis 2011. http://dx.doi.org/10.1186/1476-511X-10-126.
16. NaruszewiczM, Johansson ML, Zapolska-Downar D, Bukowska H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr 2002;6:1249-55. (Pubitemid 35416559)
17. Nguyen TD, Kang JH, LeeMS. Characterization of Lactobacillus plantarumPH04, a potential probiotic bacterium with cholesterol-lowering effects. Int J Food Microbiol 2007;3:358-61. (Pubitemid 46123645)
18. Hatakka K, Mutanen M, Holma R, Saxelin M, Korpela R. Lactobacillus rhamnosus LC705 together with administered in capsules is ineffective in lowering serum lipids. J Am Coll Nutr 2008;4:441-7.
19. de Roos NM, Schouten G, Katan MB. Yogurt enriched with Lactobacillus acidophilus does not lower blood lipids in healthy men and women with normal to borderline high serum cholesterol levels. Eur J Clin Nutr 1999;4:277-80. (Pubitemid 29164259)
20. XieN, Cui Y, Yin YN, Zhao X, Yang YW,Wang ZG, et al. Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol diet. BMC Complement Altern Med 2011. http://dx.doi.org/10. 1186/1472-6882-11-53.
21. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996;5:707-27. (Pubitemid 26105783)
22. Xu S, Little PJ, Lan T, Huang Y, Le K, Wu X, et al. Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in Apolipoprotein-E knockout mice fed a high cholesterol diet. Arch Biochem Biophys 2011;1-2:72-9.
23. Ben-Neriah Y, Schmidt-Supprian M. Epithelial NF-kappaBmaintains host gutmicroflora homeostasis. Nat Immunol 2007;l 5:479-81. (Pubitemid 46605915)
24. Mizuno Y, Jacob RF,Mason RP. Inflammation and the development of atherosclerosis- effects of lipid-lowering therapy. J Atheroscler Thromb 2011;5:351-8.
25. Manson JE, Tosteson H, Ridker PM, Satterfield S, Hebert P, O'Connor GT, et al. The primary prevention of myocardial infarction. N Engl J Med 1992;21:1406-16.
26. Park YH, Kim JG, Shin YW, Kim HS, Kim YJ, Chun T, et al. Effects of Lactobacillus acidophilus 43121 and amixture of Lactobacillus casei and Bifidobacteriumlongumon the serum cholesterol level and fecal sterol excretion in hypercholesterolemiainduced pigs. Biosci Biotechnol Biochem 2008;2:595-600. (Pubitemid 351353678)
27. Huang Y, Wang J, Cheng Y, Zheng Y. The hypocholesterolaemic effects of Lactobacillus acidophilus American type culture collection 4356 in rats are mediated by the down-regulation of Niemann-Pick C1-Like 1. Br J Nutr 2010;6:807-12.
28. Massey LK. Effect of changing milk and yogurt consumption on human nutrient intake and serum lipoprotein. J Dairy Sci 1984;2:255-62.
29. Fak F, Bäckhed F. Lactobacillus reuteri prevents diet-induced obesity, but not atherosclerosis, in a strain dependent fashion in Apoe?/? mice. PLoS One 2012;10:e46837. http://dx.doi.org/10.1371/journal.pone.0046837.
30. Kudchodkar BJ, Pierce A, Dory L. Chronic hyperbaric oxygen treatment elicits an anti-oxidant response and attenuates atherosclerosis in apoE knockout mice. Atherosclerosis 2007;1:28-35. (Pubitemid 46776707)
31. Libby P. Inflammation in atherosclerosis. Nature 2002;6917:868-74. (Pubitemid 36019640)
32. Jessup W, Dean RT, de Whalley CV, Rankin SM, Leake DS. The role of oxidative modification and antioxidants in LDL metabolism and atherosclerosis. Adv Exp Med Biol 1990;264:139-42. (Pubitemid 20316306)
33. Fang X, Weintraub NL, Rios CD, Chappell DA, Zwacka RM, Engelhardt JF, et al. Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells. Circ Res 1998;12:1289-97. (Pubitemid 28294748)
34. Berliner JA, Gharavi NM. Endothelial cell regulation by phospholipid oxidation products. Free Radic Biol Med 2008;2:119-23.
35. Virtanen T, Pihlanto A, Akkanen S, Korhonen H. Development of antioxidant activity inmilk whey during fermentation with lactic acid bacteria. J ApplMicrobiol 2007;1: 106-15. (Pubitemid 44952793)
36. Amaretti A, di Nunzio M, Pompei A, Raimondi S, Rossi M, Bordoni A. Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities. Appl Microbiol Biotechnol 2013;2:809-17.
37. Lamon BD, Hajjar DP. Inflammation at the molecular interface of atherogenesis: an anthropological journey. Am J Pathol 2008;5:1253-64.
38. Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 1996;7:1715-22. (Pubitemid 26105480)
39. Brand K, Page S, Walli AK, Neueier D, Baeuerle PA. Role of nuclear factor-kappa B in atherogenesis. Exp Physiol 1997;2:297-304.
40. Caesar R, Fak F, Bäckhed F. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med 2010;4: 320-8.
41. Stepankova R, Tonar Z, Bartova J, Nedorost L, Rossman P, Poledne R, et al. Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet. J Atheroscler Thromb 2010;8:796-804.
42. Davies DG, Parsek MR, Pearson JP, Iqlewski BH, Costerton JW, Greenberg EP. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998;5361:295-8. (Pubitemid 28178075)
43. Kumari A, Catanzaro R, Marotta F. Clinical importance of lactic acid bacteria: a short review. Acta Biomed 2011;3:177-80.
44. Choi HJ, Shin MS, Lee SM, Lee WK. Immunomodulatory properties of Enterococcus faecium JWS 833 isolated from duck intestinal tract and suppression of Listeria monocytogenes infection. Microbiol Immunol 2012;9:613-20.